Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Synergy CHC Corp. Director's Dealing 2015

Nov 16, 2015

34910_dirs_2015-11-16_ab15a3da-3e37-429f-9d8a-740ce79bbb4b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Synergy CHC Corp. (SNYR)
CIK: 0001562733
Period of Report: 2015-11-12

Reporting Person: Knight Therapeutics (Barbados) Inc. (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-11-12 Common Stock J 5550625 Acquired 10145812 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-11-12 Warrants $0.49 J 1 Acquired 2025-11-12 Common Shares (4547243) Direct

Footnotes

F1: The shares of common stock were acquired upon the exercise of a warrant issued to the Reporting Person on November 12, 2015 for $1.00.

F2: The warrants were acquired by the Reporting Person in conjunction with the issuance of a debenture by the Reporting Person to the Issuer.